Quiz poster - hund och katt

Why does COX-2 selectivity matter in canine pain management — and is it always the safer choice? In this article, Dr. Helle Harding Poulsen explores the science behind NSAID selectivity, its clinical implications, and the misconceptions that persist in veterinary practice. With COX enzymes playing a key role in prostaglandin production, understanding which ones are inhibited is critical to balancing efficacy and safety. Read the full article for a deeper look into how COX-2 selective NSAIDs shape treatment decisions in companion animal care.

Explore the science behind Previcox®, a COX-2 selective NSAID developed exclusively for dogs, with over two decades of proven clinical efficacy and safety. Selected from over 3,000 molecules, firocoxib stands out for its targeted action and strong safety profile. This article offers a deep dive into its pharmacological foundation, development journey, and continued relevance in modern veterinary pain management. Read the full article to gain valuable insights into why Previcox® remains a trusted choice among veterinary professionals.

What drives the choice of NSAIDs in postoperative pain management — and how can veterinarians ensure optimal outcomes both in-clinic and at home? In this article, veterinary surgeon Simon Byrgersen shares practical insights from daily clinical work at OrthoVet Small Animal Clinic. Learn which factors influence NSAID selection and how evidence-based decisions can support better recovery for patients. Read the full article to explore key considerations in managing postoperative pain effectively.